| Implementation of lung cancer screening in the Veterans Health Administration LS Kinsinger, C Anderson, J Kim, M Larson, SH Chan, HA King, KL Rice, ... JAMA internal medicine 177 (3), 399-406, 2017 | 348 | 2017 |
| Lung cancer screening LT Tanoue, NT Tanner, MK Gould, GA Silvestri American journal of respiratory and critical care medicine 191 (1), 19-33, 2015 | 289 | 2015 |
| An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in … RS Wiener, MK Gould, DA Arenberg, DH Au, K Fennig, CR Lamb, ... American journal of respiratory and critical care medicine 192 (7), 881-891, 2015 | 215 | 2015 |
| The association between smoking abstinence and mortality in the National Lung Screening Trial NT Tanner, NM Kanodra, M Gebregziabher, E Payne, CH Halbert, ... American journal of respiratory and critical care medicine 193 (5), 534-541, 2016 | 212 | 2016 |
| Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy NJ Pastis, LB Yarmus, F Schippers, R Ostroff, A Chen, J Akulian, ... Chest 155 (1), 137-146, 2019 | 207 | 2019 |
| Addressing disparities in lung cancer screening eligibility and healthcare access. An official American Thoracic Society statement MP Rivera, HA Katki, NT Tanner, M Triplette, LC Sakoda, RS Wiener, ... American journal of respiratory and critical care medicine 202 (7), e95-e112, 2020 | 166 | 2020 |
| Management of lung nodules and lung cancer screening during the COVID-19 pandemic: CHEST expert panel report PJ Mazzone, MK Gould, DA Arenberg, AC Chen, HK Choi, FC Detterbeck, ... Chest 158 (1), 406-415, 2020 | 157 | 2020 |
| Assessment of plasma proteomics biomarker’s ability to distinguish benign from malignant lung nodules: results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) trial GA Silvestri, NT Tanner, P Kearney, A Vachani, PP Massion, A Porter, ... Chest 154 (3), 491-500, 2018 | 146 | 2018 |
| Management of pulmonary nodules by community pulmonologists: a multicenter observational study NT Tanner, J Aggarwal, MK Gould, P Kearney, G Diette, A Vachani, ... Chest 148 (6), 1405-1414, 2015 | 146 | 2015 |
| Racial differences in outcomes within the National Lung Screening Trial. Implications for widespread implementation NT Tanner, M Gebregziabher, C Hughes Halbert, E Payne, LE Egede, ... American journal of respiratory and critical care medicine 192 (2), 200-208, 2015 | 143 | 2015 |
| Lung cancer: progress in diagnosis, staging and therapy SG Spiro, NT Tanner, GA Silvestri, SM Janes, E Lim, JF Vansteenkiste, ... Respirology 15 (1), 44-50, 2010 | 127 | 2010 |
| Primary care provider and patient perspectives on lung cancer screening. A qualitative study NM Kanodra, C Pope, CH Halbert, GA Silvestri, LSJ Rice, NT Tanner Annals of the American Thoracic Society 13 (11), 1977-1982, 2016 | 125 | 2016 |
| Standard bronchoscopy with fluoroscopy vs thin bronchoscopy and radial endobronchial ultrasound for biopsy of pulmonary lesions: a multicenter, prospective, randomized trial NT Tanner, L Yarmus, A Chen, JW Memoli, HJ Mehta, NJ Pastis, H Lee, ... Chest 154 (5), 1035-1043, 2018 | 117 | 2018 |
| Racial and ethnic disparities in early-stage lung cancer survival S Soneji, NT Tanner, GA Silvestri, CS Lathan, W Black Chest 152 (3), 587-597, 2017 | 115 | 2017 |
| Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer JSW Memoli, E El-Bayoumi, NJ Pastis, NT Tanner, M Gomez, JT Huggins, ... Chest 140 (6), 1550-1556, 2011 | 108 | 2011 |
| Physician assessment of pretest probability of malignancy and adherence with guidelines for pulmonary nodule evaluation NT Tanner, A Porter, MK Gould, XJ Li, A Vachani, GA Silvestri Chest 152 (2), 263-270, 2017 | 94 | 2017 |
| The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules HJ Mehta, JG Ravenel, SR Shaftman, NT Tanner, L Paoletti, KK Taylor, ... Chest 145 (3), 464-472, 2014 | 93 | 2014 |
| Incorporating coexisting chronic illness into decisions about patient selection for lung cancer screening. An official American Thoracic Society research statement MP Rivera, NT Tanner, GA Silvestri, FC Detterbeck, MC Tammemägi, ... American journal of respiratory and critical care medicine 198 (2), e3-e13, 2018 | 83 | 2018 |
| Screening and early detection efforts in lung cancer NM Kanodra, GA Silvestri, NT Tanner Cancer 121 (9), 1347-1356, 2015 | 73 | 2015 |
| Clinical aspects of lung cancer GA Silvestri, NJ Pastis, NT Tanner, JR Jett Murray and Nadel's Textbook of Respiratory Medicine: Volume 1, 2, Sixth …, 2015 | 63 | 2015 |
